Daniel Utzschneider
danielutzschneider.bsky.social
Daniel Utzschneider
@danielutzschneider.bsky.social
Lab Head @thedohertyinst.bsky.social | University of Melbourne
CSL Centenary & NHMRC Fellow
views my own

https://www.doherty.edu.au/people/dr-daniel-utzschneider
Pinned
Excited for our lab's FIRST paper #ScienceImmunology! 🎉

Led by @categraca.bsky.social & Amania Sheikh, with amazing collabs from Axel Kallies, Dane Newman, & @rickyjohnstone.bsky.social

Huge thanks to reviewers & @claireolingy.bsky.social 🙌

#Tpex #onthescoreboard

www.science.org/doi/full/10....
Stem-like memory and precursors of exhausted T cells share a common progenitor defined by ID3 expression
ID3 defines stem-like T cells with high developmental potential that sustain T cell responses to chronic infection and cancer.
www.science.org
Reposted by Daniel Utzschneider
Online now: Microbiota-derived butyrate promotes a FOXO1-induced stemness program and preserves CD8+ T cell immunity against melanoma
Microbiota-derived butyrate promotes a FOXO1-induced stemness program and preserves CD8+ T cell immunity against melanoma
The gut microbiome impacts immunity at various levels, including response to immunotherapy. Bachem et al. find that metabolic pathways shared across different microbiota constituents, including SCFA synthesis, modulate stem-like tumor-specific CD127+CD8+ T cells in the tumor-draining lymph node and impact control of melanoma.
dlvr.it
November 3, 2025 at 3:48 PM
Reposted by Daniel Utzschneider
‼️Deadline approaching - Don't miss your chance to submit an oral abstract for 16th Annual Lorne Infection & Immunity Conference
📍Held 18-20 of February 2026 at the Mantra Lorne

📝 Career Development Awards also available

Apply at www.lorneinfectionimmunity.org

Deadline: Friday, 10th of October
October 8, 2025 at 9:22 AM
Reposted by Daniel Utzschneider
CSH Asia meeting on Immune Tolerance #CSHA
August 20, 2025 at 9:02 AM
Reposted by Daniel Utzschneider
TGFβ-driven, HOBIT-dependent tissue-residency programs promote tumor-infiltration of CD8 T cells, but disruption of TGFβ in these tumor-infiltrating cells enhances tumor control @natimmunol.nature.com www.nature.com/articles/s41...
www.nature.com/articles/s41...
July 29, 2025 at 5:19 PM
Congrats @yannick-alexandre.bsky.social and team. Great study
June 5, 2025 at 1:09 AM
Reposted by Daniel Utzschneider
We're looking for an experienced lab manager to join our wonderful team investigating fundamental T cell biology 🤓
careers.pageuppeople.com/513/cw/en/jo...
Job Search
careers.pageuppeople.com
May 12, 2025 at 9:23 AM
Great meeting to (be) lock(ed) in!
Register TODAY: Melbourne Immunotherapy Network, 2-day Spring Symposium, Pentridge Prison, Coburg! 2-3 Sept '25.
Student Early Bird: $250, inc. conference dinner (No metal prison trays, I promise!)
Click below to register and submit your Abstract.
www.melbourneimmunotherapy.org/registration
March 11, 2025 at 5:17 AM
Reposted by Daniel Utzschneider
We are recruiting a group leader in laboratory research at Peter Mac Cancer Centre in
Melbourne, Australia 🔬🦘💥

Work in a cutting edge research environment in a vibrant world city!

We value research excellence, creativity and diversity.

Join us!

careers.petermac.org/job/MELBOURN...
Group Leader
Group Leader
careers.petermac.org
March 5, 2025 at 8:04 AM
Reposted by Daniel Utzschneider
Inexplicably, US administration has launched an unprecedented assault on science, on research institutions & on vital international organizations & initiatives.

An assault on science anywhere is an assault on science everywhere; the global community must unite
🧪
www.nature.com/articles/d41...
Trump 2.0: an assault on science anywhere is an assault on science everywhere
US President Donald Trump is taking a wrecking ball to science and to international institutions. The global research community must take a stand against these attacks.
www.nature.com
February 25, 2025 at 7:48 PM
Reposted by Daniel Utzschneider
Check out our new paper!
February 22, 2025 at 8:44 PM
Reposted by Daniel Utzschneider
In the media over the weekend, groundbreaking research from Peter Mac & The Doherty has uncovered a new way to enhance the immune system’s ability to fight cancer.

Work at Peter Mac led by @JohnstoneRicky and Dane Newman. More via @australian or here: www.petermac.org/about-us/new...
New immune system discovery could boost cancer treatment effectiveness - Peter MacCallum Cancer Centre
www.petermac.org
February 2, 2025 at 11:39 PM
Reposted by Daniel Utzschneider
Very excited about this collaborative study between @petermaccc.bsky.social @danielutzschneider.bsky.social and Kallies lab
January 31, 2025 at 11:46 PM
Reposted by Daniel Utzschneider
ID3 defines stem-like T cells with high developmental potential that sustain T cell responses to chronic infection and cancer
www.science.org/doi/10.1126/...
@sciimmunology.bsky.social
January 31, 2025 at 11:23 PM
Reposted by Daniel Utzschneider
Very happy to share our new work!
January 31, 2025 at 8:58 PM
Excited for our lab's FIRST paper #ScienceImmunology! 🎉

Led by @categraca.bsky.social & Amania Sheikh, with amazing collabs from Axel Kallies, Dane Newman, & @rickyjohnstone.bsky.social

Huge thanks to reviewers & @claireolingy.bsky.social 🙌

#Tpex #onthescoreboard

www.science.org/doi/full/10....
Stem-like memory and precursors of exhausted T cells share a common progenitor defined by ID3 expression
ID3 defines stem-like T cells with high developmental potential that sustain T cell responses to chronic infection and cancer.
www.science.org
January 31, 2025 at 7:51 PM
Really enjoyed writing this News & Views for @natimmunol.bsky.social on @tcellogic.bsky.social & teams recent @science.org paper - the first one 😉

Really beautiful work!!!

www.nature.com/articles/s41...
January 31, 2025 at 10:31 AM
Reposted by Daniel Utzschneider
🐳 Join us in sunny Lorne, Australia next month, 19-21 Feb, for the @theviin.bsky.social Infection and Immunity Conference. 🪼 Absolutely great line-up this year! In person (sea-side🐚) and virtual registration options available too. Don't miss out- www.lorneinfectionimmunity.org/registration
January 29, 2025 at 5:17 AM
Reposted by Daniel Utzschneider
Share your #cancer #immunology research w/ #CSCancerImmunity2025 organizers Ignacio Melero, Ira Mellman, Fabiola Rivas @cp-immunity.bsky.social
& Montse Rojo de la Vega @cp-cancercell.bsky.social . hubs.li/Q033hK4y0
January 21, 2025 at 5:44 PM
Reposted by Daniel Utzschneider
Special thanks to my PhD mentor Rafi, my co-first author, Rajesh Valanparambil, and all the rest of our co-authors.

Image above shows CD8 T cells asking a crystal ball to predict infection outcome. Credit: ChatGPT4

Also see our companion paper from Dietmar Zehn's lab: tinyurl.com/yck3mdup
Precursors of exhausted T cells are preemptively formed in acute infection - Nature
Nature - Precursors of exhausted T cells are preemptively formed in acute infection
tinyurl.com
January 15, 2025 at 10:23 PM
Two studies published in @nature.com today showing that Tpex-like cells develop independent from acute or chronic infection

#Tpex

www.nature.com/articles/s41...
January 9, 2025 at 8:33 AM
Reposted by Daniel Utzschneider
We’ve jumped on board fully here on 🦋
A starter pack of those working on our favourite cell … the T cell 🥰🙈🥰

If you want an add let us know

go.bsky.app/8B5P25c
November 19, 2024 at 10:11 PM
Reposted by Daniel Utzschneider
I made a starter pack for those of us interested in or working on T cells. Let me know if you would like to be added or know somebody that should be added.

Looking forward to scientific discussions and updates on our favorite immune cell type!
November 18, 2024 at 5:19 PM
Congrats @nanaborsa.bsky.social
Amazing news!!!
huuuuuge congrats to @nanaborsa.bsky.social 💪🏽💪🏽💪🏽 immunologist extraordinaire - cannot wait to welcome you to Basel
The SNSF (@snsf-ch.bsky.social) awards Starting Grants to outstanding young researchers in Switzerland. In this year's call, five of the successful researchers plan to carry out their projects at the University of Basel.
www.unibas.ch/en/News-Even...
November 15, 2024 at 11:18 AM